DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Mianserin is an investigational drug.
There have been 5 clinical trials for Mianserin. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2009.
The most common disease conditions in clinical trials are Depressive Disorder, Major, Depressive Disorder, and Depression. The leading clinical trial sponsors are Hospital Universitari de Bellvitge, Duke University, and Forest Laboratories.
Recent Clinical Trials for Mianserin
|Treatment of Sleep Disturbances in Trauma-affected Refugees||Danish Center for Sleep Medicine||Phase 4|
|Treatment of Sleep Disturbances in Trauma-affected Refugees||Mental Health Services in the Capital Region, Denmark||Phase 4|
|Pharmacovigilance in Gerontopsychiatric Patients||Hannover Medical School||Phase 3|